PRLD
Prelude Therapeutics Incorporated - Common Stock (PRLD)
$70
About Prelude Therapeutics Incorporated - Common Stock (PRLD)
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Details
Daily high
$4.71
Daily low
$4.65
Price at open
$4.70
52 Week High
$6.83
52 Week Low
$1.02
Market cap
375.1M
Dividend yield
-
Volume
9,664
Avg. volume
476,597
P/E ratio
-5.97
Prelude Therapeutics Incorporated - Common Stock News
Details
Daily high
$4.71
Daily low
$4.65
Price at open
$4.70
52 Week High
$6.83
52 Week Low
$1.02
Market cap
375.1M
Dividend yield
-
Volume
9,664
Avg. volume
476,597
P/E ratio
-5.97